Nov. 9 at 12:35 PM
$SSKN I am slowly re-entering this name in the 1.5$ range. Multiple good news recently = expect a decent 2026:
-Kicking out by injunction a fake competitor, while they become the dominant player nationwide and may even receive a settlement payment.
-New patents approved.
-New CPT codes for higher reimbursement in a variety of inflammatory conditions.
-Highly focused CEO and management to make the company efficiency and profitable with redeployment of assets.
-Stronger balance sheet after the Sep equity raise.
$XBI $IBB